ISHRS Ms Small Growth

SiTime Announces Expansion of $1.2 Billion Convertible Senior Notes Pricing

Lattice Semiconductor Q1 Revenue Surges 42% to $170.9M, Announces $1.65B Acquisition of AMI

Lumentum Executive VP Vincent Retort Sells 6,482 Shares for Approximately $6.25 Million

Roku CFO Dan Jedda Sells 7,000 Shares, Pushing Stock Down 2.9%

Roku Launches Creator Hub and Introduces New Creator FAST Channels on Roku Channel

SiTime Plans $1.1B Convertible Note Issuance to Acquire Part of Renesas Electronics

MACOM Reports Q2 2026 Earnings, Issues Q3 Guidance Driven by AI Demand

Aixtron Secures Multiple Orders from Lumentum for MOCVD Systems to Meet AI Optical Link Demands

MACOM Director Peter Y. Chung Sells 43,268 Shares at $378.2 Per Share

Thrivent Increases LSCC Stake by 33.9%, Analysts Raise Price Targets

Abacus Wealth Increases Stake in Sterling Infrastructure as Earnings Beat Expectations

Revolution Medicines Pancreatic Cancer Drug Trial Shows Positive Results, US Cancer Center Launches Expanded Access Plan Amid Stock Fluctuation

RBC Bearings released FY2026 Annual Earnings on May 15 Pre-Market (EST), actual revenue USD 1.871 B (forecast USD 1.867 B), actual EPS USD 9.09 (forecast USD 8.8276)

RBC Bearings released FY2026 Q4 earnings on May 15 Pre-Market (EST), actual revenue USD 518 M (forecast USD 506.77 M), actual EPS USD 2.8887 (forecast USD 2.5666)

RBC Bearings Q4 Revenue Surges 18% Beating Estimates, Forecasts $500M-$510M Net Sales for FY2027 Q1

Zacks Upgrades MACOM Technology Solutions to "Strong Buy", Multiple Brokerages Raise Price Targets

US Clinics Race to Enroll Patients in Revolution Medicines Pancreatic Cancer Drug Early Access Plan After FDA Approval

Lattice Semiconductor Reports Strong Q1 Earnings

Lumentum Director Ian Small Sells 3,500 Shares

Brian Lillie Sells Lumentum Shares

OPTIMI HEALTH CORP

HCW Biologics

Silexion Therapeutics

Vida Global

GCL Global

BiomX

MetaVia

Micware

MicroAlgo

ISCG

The comparison between iShares Morningstar Small-Cap Growth ETF (ISCG) and Vanguard Small-Cap Growth ETF (VBK) highlights key differences in fees, liquidity, and performance. ISCG has a higher one-year return (24.7% vs. 23.0%) and a slightly better dividend yield (0.6% vs. 0.5%), while VBK boasts lower fees (0.05% vs. 0.06%) and significantly higher assets under management ($40 billion vs. $881.5 million), indicating better liquidity. Both ETFs provide diversified exposure to U.S. small-cap growth stocks, but ISCG offers a broader portfolio with 963 stocks compared to VBK's 579. Investors should weigh these factors when choosing between the two.

nasdaq

VG S-Cp Grw

ISCG vs. VBK: Which ETF Offers Lower Fees, More Liquidity, and Greater Returns?

The article compares two small-cap growth ETFs: ISCG and RZG. ISCG has a lower expense ratio (0.06% vs. 0.35%) and is significantly larger in assets, offering broader diversification with nearly 1,000 stocks. RZG, with about 130 stocks, focuses more on healthcare and technology. Both funds have shown similar performance, but ISCG's lower costs and diversification may appeal more to investors. The article also highlights the importance of cost and portfolio construction in small-cap growth investing.

Rydx S&P S-Cp 600 Pure Grw

ISCG vs. RZG: Which Small-Cap Growth ETF Fits Your Portfolio?

The iShares Morningstar Small-Cap Growth ETF (ISCG) offers a lower expense ratio and broader portfolio compared to the iShares S&P Small-Cap 600 Growth ETF (IJT), which provides a higher dividend yield and milder drawdowns. ISCG holds nearly 1,000 stocks with a heavier tilt towards industrials, while IJT has around 355 stocks with a profitability screen. Investors seeking broad exposure may prefer ISCG, while those valuing quality may opt for IJT. Both funds target U.S. small-cap growth stocks but differ in risk and portfolio construction.

iShares Small Cap 600

IJT Plays Small-Cap Growth With Guardrails, ISCG Goes All In

ISHRS Ms Small Growth(ISCG.US)

ISCG vs. VBK: Which ETF Offers Lower Fees, More Liquidity, and Greater Returns?

ISCG vs. RZG: Which Small-Cap Growth ETF Fits Your Portfolio?

IJT Plays Small-Cap Growth With Guardrails, ISCG Goes All In